(Stroke. 2007;38:3292.)
© 2007 American Heart Association, Inc.
Case Report |
From the Divisions of Cardiovascular and Internal Medicine, Department of Medicine, University of Wisconsin Hospital and Clinics, Madison, Wisc.
Correspondence to Abdul Hakeem, MD, University of Wisconsin Hospital and Clinics, 2705 University Avenue #11, Madison, WI 53705. E-mail a.hakeem{at}hosp.wisc.edu
| Abstract |
|---|
|
|
|---|
Summary of Case— A previously healthy 64-year-old woman with no history of vascular disease was found unresponsive at home. She was taken to the emergency room where a CT head revealed an SAH due to a ruptured aneurysm of the posterior communicating artery. On admission, an ECG showed deeply inverted T-waves and QT prolongation, typical of SAH. Cardiac troponin was measured at 1.2 ng/mL, and later increased to 3.7 ng/mL. A transthoracic echocardiogram on the next day revealed a large left ventricular wall abnormality, characteristic of apical ballooning with an ejection fraction of 25% to 30%. The patient remained hemodynamically stable and was started on low dose ß-blocker and angiotensin-converting enzyme inhibitor. She had an uneventful cardiac recovery within 5 days at which time a repeat transthoracic echocardiogram revealed a normal ejection fraction with no wall motion abnormality.
Conclusions— This report adds to the growing list of "stressors" for Takotsubo cardiomyopathy. Clinicians should be aware of the existence and the typical clinical manifestations of this syndrome, which is increasingly recognized in various populations. In particular, neurologists should consider this syndrome in the differential diagnosis of ECG changes and apical wall motion abnormalities in patients with SAH. Prognosis is generally very good with full recovery in most patients; however, there may be increased morbidity associated in patients with SAH.
Key Words: Broken Heart Syndrome subarachnoid hemorrhage Takotsubo cardiomyopathy
| Introduction |
|---|
|
|
|---|
Takotsubo cardiomyopathy, also known as transient left ventricular apical ballooning (LVAB) syndrome has recently been an increasingly recognized entity characterized by transient, virtually global LV dysfunction consisting of akinesia of the LV apex in response to sudden emotional or physical stress, predominantly in postmenopausal women as seen in our case.8–11 It is associated with minimal cardiac enzyme release and has characteristically normal coronary arteries on angiography in contrast to acute coronary syndromes (ACS).9,10 Recently, reports have emerged linking transient LVAB with SAH.13–16 With a unifying pathophysiology of excessive sympathetic discharge, transient LVAB may represent a variant of RWMAs associated with SAH.12–15
| Clinical Summary |
|---|
|
|
|---|
|
|
| Discussion |
|---|
|
|
|---|
Also called Human Stress Cardiomyopathy and Broken Heart Syndrome,9 this constellation of findings includes sudden onset of chest symptoms, ECG changes consistent with myocardial ischemia, characteristic transient LV dysfunction affecting the apical region and no significant coronary stenosis on angiography.
Although originally reported in Japan, it is increasingly being recognized in Europe and North America.10,11 Almost 90% of reported patients are female and only few were younger than 50 years of age.10,11 Important influences of female hormones on sympathetic neuromodulation, coronary vasoreactivity and postmenopausal alteration in endothelial function have been proposed as possible mechanisms.10,17
Transient LVAB usually masquerades an acute coronary syndrome with a preceding physical or emotional stressor.9 Most patients present with chest pain or dyspnea.10,11 The ECG at presentation shows ST-segment elevation or T-wave inversion, and pathological Q waves are present in almost 40% of patients. Furthermore, cardiac biomarker levels are frequently raised, mimicking acute MI, and LV function is impaired with regional wall-motion abnormalities. However, coronary angiography is normal in most patients and may show mild, nonobstructive coronary lesions (50% luminal diameter stenosis).9–11 Differentiating transient LVAB from acute MI is hence important, because misdiagnosis may result in treatment with thrombolytic agents and may pose patients at unnecessary risk of bleeding.10,11
Several possible etiologies have been proposed for transient LVAB. Because of its association with emotional or physical stress, catecholamine-mediated multivessel epicardial spasm, microvascular coronary spasm, or possible direct catecholamine-mediated myocyte injury have been advocated as possible pathophysiological mechanisms.9–11 Like neurogenic stunned myocardium, excessive catecholamine release is thought by many to play a key role in LVAB in patients with SAH.12–15 This theory has also been supported by the association of transient LVAB with syndromes that involve excessive catecholamine release, such as pheochromocytomas.10,11 Furthermore, several studies have demonstrated the deleterious effect that excessive catecholamines can have on the myocyte.7,9,10 Elevated plasma catecholamines levels were found in almost 75% of the evaluated patients in a systematic review of all the published literature so far.10 In studies of patients with transient LVAB, however, the results of catecholamine assays have varied widely, calling the causal relationship between catecholamines and transient LVAB into question.10,11 Another postulation is spontaneous multivessel epicardial spasm—with ergonovine or acetylcholine infusion, it was described in <30% of patients.11,18
Another etiologic theory holds that transient LVAB could be related to perfusion problems in a single coronary artery, specifically a long wrap-around left anterior descending artery that supplies not only the anterior LV wall but also the LV apex. Several studies have demonstrated that patients with transient LVAB often have a long wrap-around artery.19 Other studies have suggested that a temporary intraventricular gradient may be the cause of transient LVAB. These studies draw from the fact that an elevated intraventricular pressure gradient is often observed in patients with transient LVAB, and that this gradient typically resolves when LV function returns.20
Furthermore, there is some evidence suggesting that the apical myocardium may be more responsive to sympathetic stimulation and may be more vulnerable to sudden catecholamine surges.21 A longitudinal, base-to-apex decline in LV myocardial perfusion, as described in patients with coronary risk factors, was also proposed as a possible alternative explanation.22
The association of transient LVAB syndrome with SAH represents only a small fraction of the cardiac complications seen with SAH.12–15 A recent study by Banki et al7 found that in a cohort of 173 patients with SAH, 15% had a left ventricular EF <50% by echocardiography, whereas 13% were found to have a RWMA. Of the RWMAs, the majority involves the basal and middle ventricular portions of the anteroseptal and anterior walls; rarely is the apex involved. Furthermore, only 66% of individuals with left ventricular dysfunction were found to have recovered their EF, whereas past studies have found that >80% of individuals with transient LVAB syndrome have full or near-full recovery of their LV function within days to weeks of onset.11 The largest series of Takotsubo cardiomyopathy associated with SAH has been documented by Lee et al.15 They identified 8 patients meeting echocardiographic criteria for Takotsubo cardiomyopathy. All 8 patients were women with severe grade SAH. Takotsubo cardiomyopathy was associated with pulmonary edema, prolonged intubation and cerebral vasospasm. Transient LVAB syndrome, then, may represent a subsection of RWMAs with apical akinesia and sparing of the basal segments called Takotsubo cardiomyopathy.
Patients with transient LVAB syndrome have generally a benign prognosis. Only 1.1% of reported patients died during the hospitalization period and almost all surviving patients recovered fully.10,11 Whereas it carries a favorable prognosis generally, this pattern of cardiac dysfunction in SAH has been associated with increased overall morbidity.12–15 It may be reasonable to consider Transthoracic echocardiography in patients with SAH, ECG abnormalities and cardiac enzyme leak for risk stratification and adequate hemodynamic management. Additional studies are warranted to better elucidate the pathomechanisms of this entitity.
| Acknowledgments |
|---|
None.
Received January 24, 2007; revision received May 9, 2007; accepted May 14, 2007.
| References |
|---|
|
|
|---|
2. Zaroff J, Rordorf G, Newell J, Ogilvy C, Levinson J. Cardiac outcome in patients with subarachnoid hemorrhage and electrocardiographic abnormalities. Neurosurgery. 1999; 44: 34–39.[Medline] [Order article via Infotrieve]
3. Bulsara KR, McGirt MJ, Liao L, Villavicencio AT, Borel C, Alexander MJ, Friedman AH. Use of the peak troponin value to differentiate myocardial infarction from reversible neurogenic left ventricular dysfunction associated with aneurysmal subarachnoid hemorrhage. J Neurosurg. 2003; 98: 524–528.[Medline] [Order article via Infotrieve]
4. Tung P, Kopelnik A, Banki N, Ong K, Ko N, Lawton MT, Gress D, Drew B, Foster E, Parmley W, Zaroff J. Predictors of neurocardiogenic injury after subarachnoid hemorrhage. Stroke. 2004; 35: 548–551.
5. Naidech AM, Kreiter KT, Janjua N, Ostapkovich ND, Parra A, Commichau C, Fitzsimmons BF, Connolly ES, Mayer SA. Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage. Circulation. 2005; 112: 2851–2856.
6. Banki N, Kopelnik A, Tung P, Lawton MT, Gress D, Drew B, Dae M, Foster E, Parmley W, Zaroff J. Prospective analysis of prevalence, distribution, and rate of recovery of left ventricular systolic dysfunction in patients with subarachnoid hemorrhage. J Neurosurg. 2006; 105: 15–20.[Medline] [Order article via Infotrieve]
7. Banki NM, Kopelnik A, Dae MW, Miss J, Tung P, Lawton MT, Drew BJ, Foster E, Smith W, Parmley WW, Zaroff JG. Acute neurocardiogenic injury after subarachnoid hemorrhage. Stroke. 2005; 112: 3314–3319.
8. Ibanez B, Benezet-Mazuecos J. Takotsubo Syndrome: A Bayesian approach to interpreting its pathogenesis. Mayo Clin Proc. 2006; 81: 732–735.
9. Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G, Wu KC, Rade JJ, Bivalacqua TJ, Champion HC. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med. 2005; 352: 539–548.
10. Gianni M, Dentali F, Grandi AM, Sumner G, Hiralal R, Lonn E. Apical Ballooning Syndrome or Takotsubo cardiomyopathy: a systematic review. Eur Heart J. 2006; 27: 1523–1529.
11. Bybee KA, Kara T, Prasad A, Lerman A, Barsness GW, Wright RS, Rihal CS. Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction. Ann Intern Med. 2004; 141: 858–865.
12. Ono Y, Kawamura T, Ito J, Kanayama S, Miura T, Kikuchi F. Ampulla (Takotsubo) cardiomyopathy associated with subarachnoid hemorrhage worsening in the late phase of vasospasm. Neurol Med Chir (Tokyo). 2004; 44: 72–74.[CrossRef][Medline] [Order article via Infotrieve]
13. Inoue F, Tsuzuki T, Thoma Y, Shiono S, Tabuse H, Hoshida T, Saito Y. Subarachnoid hemorrhage complicated with different manifestations of transient abnormal left ventricular wall motion: two case reports. J Cardiol. 2006; 47: 245–254.[Medline] [Order article via Infotrieve]
14. Otomo S, Sugita M, Shimoda O, Terasaki H. Two cases of transient Left Ventricular Apical Ballooning Syndrome associated with subarachnoid hemorrhage. Anesth Analg. 2006; 103: 583–586.
15. Lee VH, Connolly HM, Fulgham JR, Manno EM, Brown RD, Wijdicks EF. Tako-tsubo cardiomyopathy in aneurysmal subarachnoid hemorrhage: an underapprecaited ventricular dysfunction. J Neurosurg. 2006; 105: 264–270.[Medline] [Order article via Infotrieve]
16. Dote K, Sato H, Tateishi H, Uchida T, Ishihara M. Myocardial stunning due to simultaneous multivessel coronary spasms: a review of 5 cases. J Cardiol. 1991; 21: 203–214.[Medline] [Order article via Infotrieve]
17. Sader MA, Celermajer DS. Endothelial function, vascular reactivity and gender differences in the cardiovascular system. Cardiovasc Res. 2002; 53: 597–604.
18. Abe Y, Kondo M, Matsuoka R, Araki M, Dohyama K, Tanio H. Assessment of clinical features in transient left ventricular apical ballooning. J Am Coll Cardiol. 2003; 41: 737–742.
19. Ibanez B, Navarro F, Farre J, Marcos-Alberca P, Orejas M, Rabago R, Rey M, Romero J, Iniquez A, Cordoba M. Tako-tsubo Syndrome associated with a long course of the left anterior descending coronary artery along the apical diaphragmatic surface of the left ventricle. Rev Esp Cardiol. 2004; 57: 209–216.[CrossRef][Medline] [Order article via Infotrieve]
20. Villareal RP, Achari A, Wilansky S, Wilson J. Anteroapical stunning and left ventricular outflow tract obstruction. Mayo Clin Proc. 2001; 76: 79–83.[Abstract]
21. Mori H, Ishikawa S, Kojima S, Hayashi J, Watanabe Y, Hoffman JI, Okino H. Increased responsiveness of left ventricular apical myocardium to adrenergic stimuli. Cardiovasc Res. 1993; 27: 192–198.
22. Hernandez-Pampaloni M, Keng FY, Kudo T, Sayre JS, Schelbert HR. Abnormal longitudinal, base-to-apex myocardial perfusion gradient by quantitative blood flow measurements in patients with coronary risk factors. Circulation. 2001; 31: 527–532.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |